Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated d...

por Taylor, Peter C, Takeuchi, Tsutomu, Burmester, Gerd R, Durez, Patrick, Smolen, Josef S, Deberdt, Walter, Issa, Maher, Terres, Jorge Ross, Bello, Natalia, Winthrop, Kevin L
Publicado 2022

Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy

por Taylor, Peter C., Alten, Rieke, Álvaro Gracia, Jose María, Kaneko, Yuko, Walls, Chad, Quebe, Amanda, Jia, Bochao, Bello, Natalia, Terres, Jorge Ross, Fleischmann, Roy
Publicado 2022